1. Home
  2. RVPH

RVPH

Reviva Pharmaceuticals Holdings Inc.

Logo Reviva Pharmaceuticals Holdings Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-23-2024 1:31pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Founded: 2006 Country:
United States
United States
Employees: N/A City: CUPERTINO
Market Cap: 84.3M IPO Year: N/A
Target Price: $16.75 AVG Volume (30 days): 309.4K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.65 EPS Growth: N/A
52 Week Low/High: $2.67 - $9.25 Next Earning Date: 04-15-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: